Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy.
暂无分享,去创建一个
Kevin Hartman | Ayyalusamy Ramamoorthy | Jiadi Xu | Jeffrey R Brender | J. Brender | R. Nanga | A. Ramamoorthy | Jiadi Xu | Ravi Prakash Reddy Nanga | K. Hartman | Vivekanandan Subramanian | Vivekanandan Subramanian
[1] A. Gronenborn,et al. Determination of three-dimensional structures of proteins by simulated annealing with interproton distance restraints. Application to crambin, potato carboxypeptidase inhibitor and barley serine proteinase inhibitor 2. , 1988, Protein engineering.
[2] C. Dobson,et al. On the role of the C-terminus of alpha-calcitonin-gene-related peptide (alpha CGRP). The structure of des-phenylalaninamide37-alpha CGRP and its interaction with the CGRP receptor. , 1993, The Biochemical journal.
[3] S. Jayasinghe,et al. Lipid membranes modulate the structure of islet amyloid polypeptide. , 2005, Biochemistry.
[4] C. Baldauf,et al. Identification of the key residue of calcitonin gene related peptide (CGRP) 27-37 to obtain antagonists with picomolar affinity at the CGRP receptor. , 2006, Journal of medicinal chemistry.
[5] U. Aebi,et al. Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. , 2004, Journal of molecular biology.
[6] Maarten F. M. Engel,et al. Islet amyloid polypeptide‐induced membrane leakage involves uptake of lipids by forming amyloid fibers , 2004, FEBS letters.
[7] Andrew D. Miranker,et al. Direct detection of transient α‐helical states in islet amyloid polypeptide , 2007 .
[8] Maarten F. M. Engel,et al. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.
[9] T. Hauß,et al. Neutron diffraction reveals sequence‐specific membrane insertion of pre‐fibrillar islet amyloid polypeptide and inhibition by rifampicin , 2005, FEBS letters.
[10] J. Brender,et al. Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. , 2008, Journal of the American Chemical Society.
[11] E. Roberts,et al. Turn structures in CGRP C-terminal analogues promote stable arrangements of key residue side chains. , 2001, Biochemistry.
[12] Ad Bax,et al. Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.
[13] S. Grzesiek,et al. NMRPipe: A multidimensional spectral processing system based on UNIX pipes , 1995, Journal of biomolecular NMR.
[14] T. Rink,et al. 8–37h‐CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo , 1991, FEBS letters.
[15] A. Ramamoorthy,et al. Conformational studies of human islet amyloid peptide using molecular dynamics and simulated annealing methods. , 1998, Biopolymers.
[16] Ueli Aebi,et al. The parallel superpleated beta-structure as a model for amyloid fibrils of human amylin. , 2005, Journal of molecular biology.
[17] D. Craik,et al. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.
[18] J. Brender,et al. Membrane fragmentation by an amyloidogenic fragment of human Islet Amyloid Polypeptide detected by solid-state NMR spectroscopy of membrane nanotubes. , 2007, Biochimica et biophysica acta.
[19] P. Amodeo,et al. Solution structure of human calcitonin in membrane‐mimetic environment: The role of the amphipathic helix , 1998, Proteins.
[20] J. Danielsson,et al. Positioning of the Alzheimer Aβ(1–40) peptide in SDS micelles using NMR and paramagnetic probes , 2007, Journal of biomolecular NMR.
[21] A. Miranker,et al. Conserved and cooperative assembly of membrane-bound alpha-helical states of islet amyloid polypeptide. , 2006, Biochemistry.
[22] Richard Leapman,et al. Peptide conformation and supramolecular organization in amylin fibrils: constraints from solid-state NMR. , 2007, Biochemistry.
[23] C. Betsholtz,et al. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[24] A T Brünger,et al. Torsion-angle molecular dynamics as a new efficient tool for NMR structure calculation. , 1997, Journal of magnetic resonance.
[25] Hai Lin,et al. Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[26] V. Picciarelli,et al. Channel formation by salmon and human calcitonin in black lipid membranes. , 2001, Biophysical journal.
[27] A. Miranker,et al. Phospholipid catalysis of diabetic amyloid assembly. , 2004, Journal of molecular biology.
[28] P. M. Doyle,et al. Conformational restraints revealing bioactive β‐bend structures for hα CGRP8–37 at the CGRP2 receptor of the rat prostatic vas deferens , 1999 .
[29] J. Vederas,et al. Membrane permeabilization, orientation, and antimicrobial mechanism of subtilosin A. , 2005, Chemistry and physics of lipids.
[30] S. Jayasinghe,et al. Structure of α-Helical Membrane-bound Human Islet Amyloid Polypeptide and Its Implications for Membrane-mediated Misfolding* , 2008, Journal of Biological Chemistry.
[31] Gianluigi Veglia,et al. Structures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopy. , 2008, Biochemistry.
[32] A. Bax,et al. Comparison of Structure and Dynamics of Micelle-bound Human α-Synuclein and Parkinson Disease Variants* , 2005, Journal of Biological Chemistry.
[33] D. Raleigh,et al. Effects of sequential proline substitutions on amyloid formation by human amylin20-29. , 1999, Biochemistry.
[34] C. Dobson,et al. Rational design of aggregation-resistant bioactive peptides: reengineering human calcitonin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] M Morfis,et al. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. , 1999, Molecular pharmacology.
[36] Gerard J A Kroon,et al. Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state. , 2008, Biochemistry.
[37] V. Picciarelli,et al. Effect of pH-variation on insertion and ion channel formation of human calcitonin into planar lipid bilayers. , 2006, Frontiers in bioscience : a journal and virtual library.
[38] Bernhard Pfeiffer,et al. Over one hundred peptide-activated G protein-coupled receptors recognize ligands with turn structure. , 2005, Chemical reviews.
[39] J. Pettegrew,et al. Alzheimer’s Disease: Soluble Oligomeric Aβ(1–40) Peptide in Membrane Mimic Environment from Solution NMR and Circular Dichroism Studies , 2004, Neurochemical Research.
[40] A. Bax,et al. Protein backbone angle restraints from searching a database for chemical shift and sequence homology , 1999, Journal of biomolecular NMR.
[41] S. Jayasinghe,et al. Membrane interaction of islet amyloid polypeptide. , 2007, Biochimica et biophysica acta.
[42] A. Couvineau,et al. Class-B GPCR activation: is ligand helix-capping the key? , 2008, Trends in biochemical sciences.
[43] Kevin Hartman,et al. A single mutation in the nonamyloidogenic region of islet amyloid polypeptide greatly reduces toxicity. , 2008, Biochemistry.
[44] E. Gazit,et al. The minimal amyloid‐forming fragment of the islet amyloid polypeptide is a glycolipid‐binding domain , 2006, The FEBS journal.
[45] H. Shao,et al. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.
[46] C. Aisenbrey,et al. How is protein aggregation in amyloidogenic diseases modulated by biological membranes? , 2008, European Biophysics Journal.
[47] Dong-Kuk Lee,et al. Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. , 2002, Biophysical journal.
[48] A. Pastore,et al. Dynamic properties of salmon calcitonin bound to sodium dodecyl sulfate micelles: A restrained molecular dynamics study from NMR data , 1992, Journal of biomolecular NMR.
[49] D. Raleigh,et al. Destabilization of human IAPP amyloid fibrils by proline mutations outside of the putative amyloidogenic domain: is there a critical amyloidogenic domain in human IAPP? , 2006, Journal of molecular biology.
[50] A. Miranker,et al. Amide inequivalence in the fibrillar assembly of islet amyloid polypeptide. , 2008, Protein engineering, design & selection : PEDS.
[51] Laura Zanetti Polzi,et al. Calcitonin forms oligomeric pore-like structures in lipid membranes. , 2006, Biophysical journal.
[52] A. Alexandrescu,et al. Dynamic α-Helix Structure of Micelle-bound Human Amylin* , 2009, Journal of Biological Chemistry.
[53] R. Epand,et al. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs. , 1990, Endocrinology.
[54] A. Pastore,et al. Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations. , 1991, Biochemistry.
[55] D. Raleigh,et al. A role for helical intermediates in amyloid formation by natively unfolded polypeptides? , 2009, Physical biology.
[56] S. Wimalawansa,et al. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. , 1997, Critical reviews in neurobiology.
[57] A. Kapurniotu,et al. Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt. , 2002, European journal of biochemistry.
[58] J. W. Taylor,et al. Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues. , 1999, European journal of biochemistry.
[59] U. Aebi,et al. Full-length rat amylin forms fibrils following substitution of single residues from human amylin. , 2003, Journal of molecular biology.
[60] E. Rizzarelli,et al. DSC study of the interaction of the prion peptide PrP106–126 with artificial membranes , 2001 .
[61] A. Magrì,et al. Environmental factors differently affect human and rat IAPP: conformational preferences and membrane interactions of IAPP17-29 peptide derivatives. , 2007, Chemistry.
[62] D. van der Spoel,et al. Molecular dynamics simulations of dodecylphosphocholine micelles at three different aggregate sizes: Micellar structure and chain relaxation , 2000 .
[63] E. Scharrer,et al. Amylin receptors mediate the anorectic action of salmon calcitonin (sCT) , 2000, Peptides.
[64] P. Kinnunen,et al. Islet amyloid polypeptide forms rigid lipid-protein amyloid fibrils on supported phospholipid bilayers. , 2008, Journal of molecular biology.
[65] S. Lenzen,et al. Lipid composition of glucose-stimulated pancreatic islets and insulin-secreting tumor cells , 1994, Lipids.
[66] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[67] G. Veglia,et al. Conformational preferences of the amylin nucleation site in SDS micelles: An NMR study , 2003, Biopolymers.
[68] Maarten F. M. Engel,et al. Recent Insights in Islet Amyloid Polypeptide-Induced Membrane Disruption and Its Role in β-Cell Death in Type 2 Diabetes Mellitus , 2008, Experimental diabetes research.
[69] D. Milardi,et al. Calcium-activated membrane interaction of the islet amyloid polypeptide: implications in the pathogenesis of type II diabetes mellitus. , 2008, Archives of biochemistry and biophysics.
[70] David Eisenberg,et al. Atomic structure of the cross‐β spine of islet amyloid polypeptide (amylin) , 2008, Protein science : a publication of the Protein Society.
[71] Michael F. Brown,et al. Perturbation of the hydrophobic core of lipid bilayers by the human antimicrobial peptide LL-37. , 2004, Biochemistry.